The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Bexion
A phase 1, safety and dose escalation study of BXQ-350, a nanovesicle formulation of saposin c, a modulator of sphingolipid metabolism, in patients with advanced solid malignancies.
 
Richard Charles Curry
Stock and Other Ownership Interests - Bexion
Consulting or Advisory Role - Bexion
 
Olivier Rixe
No Relationships to Disclose
 
John Charles Morris
Honoraria - CTI; Merck
Speakers' Bureau - Boehringer Ingelheim; Merck
Patents, Royalties, Other Intellectual Property - National Institutes of Health patent
 
Robert Wesolowski
Consulting or Advisory Role - Celcuity; Perthera
Speakers' Bureau - ONCOLIVE; Roche
Travel, Accommodations, Expenses - Roche
 
Emrullah Yilmaz
No Relationships to Disclose
 
John L. Villano
No Relationships to Disclose
 
Carolyn Muller
Research Funding - agenus (Inst); AstraZeneca (Inst); Genmab (Inst); Incyte (Inst); Linnaeus Therapeutics (Inst); Merck (Inst); Roche/Genentech (Inst); TapImmune Inc. (Inst); VBL Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Have a pending patent on the cancer use for R-ketorolac - not yet its own new drug. (Inst)
Other Relationship - Department of Defense; NCI; NCI
 
Trisha Michel Wise-Draper
Stock and Other Ownership Interests - High Enroll
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Caris Life Sciences; Exicure; Merck; Rakuten Medical; Shattuck Labs
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Caris Life Sciences; GlaxoSmithKline; GlaxoSmithKline; Janssen Oncology; Merck
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; bexion; Bristol-Myers Squibb; Caris Life Sciences; Caris Life Sciences; Lilly; Merck; Tesaro
 
Anne M. Noonan
Consulting or Advisory Role - Eisai; Exelixis; Helsinn Healthcare; QED Therapeutics
 
Vinay K. Puduvalli
Stock and Other Ownership Interests - Amarin Corporation; Gilead Sciences
Honoraria - Novocure; Orbus Therapeutics; SERVIER
Consulting or Advisory Role - Newave Pharmaceutical (I); NewBio; Novocure; Orbus Therapeutics; SERVIER
Research Funding - BeiGene; Bexion; InSightec; Karyopharm Therapeutics; Kazia Therapeutics; Merck; Radiomedix; Samus Therapeutics; SERVIER
 
Gilles Tapolsky
Employment - Bexion
Stock and Other Ownership Interests - Bexion
Patents, Royalties, Other Intellectual Property - Bexion
 
Ray Takigiku
Employment - Bexion
Leadership - Bexion
Stock and Other Ownership Interests - Bexion
Patents, Royalties, Other Intellectual Property - Bexion